BRIEF-EMA Says Clinical Data Published Supporting Extension Of Indication For Spikevax To Include Use In Adolescents Aged 12-17

European Medicines Agency:

* EMA PUBLISHED CLINICAL DATA SUPPORTING EXTENSION OF INDICATION FOR SPIKEVAX TO INCLUDE USE IN ADOLESCENTS AGED 12 TO 17. Further company coverage:

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)